Drug Topics

SEPTEMBER 17, 2024

The CDC recently released a report detailing 2023 statistics regarding adult obesity within the 50 US states.

281

281

PharmaVoice

SEPTEMBER 17, 2024

Big Pharma is embracing the radiopharmaceuticals boom that was a long time in the making.

182

182

Drug Topics

SEPTEMBER 17, 2024

A study found there were 216 active supportive care clinical trials and that industry sponsors rarely provided funding.

216

216

STAT

SEPTEMBER 17, 2024

Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit on Tuesday demanding that a recent Federal Trade Commission report accusing industry middlemen of raising drug prices be vacated. In scathing language, the company argued the report was “seventy-four pages of unsupported innuendo leveled … under a false and defamatory headline.

Independent Pharmacies 143

Independent Pharmacies 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 17, 2024

Greg Baker, CEO of AffirmedRx, gave a presentation at the PBMI Annual National Conference where he talked about PBM trends and their impact on employers.

216

216

Fierce Healthcare

SEPTEMBER 17, 2024

Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry. | Express Scripts is suing the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry.

136

136

Pharmacy Times

SEPTEMBER 17, 2024

Ten-year follow up data showed a sustained survival benefit with nivolumab-ipilimumab in advanced melanoma.

132

132

STAT

SEPTEMBER 17, 2024

In July, Medicare proposed to start paying for some mental health apps, in a move applauded by the developers of those treatments after years of struggling to find adoption among clinicians and patients. But it wasn’t only the startups and their supporters that took notice — some of the largest pharma and health care companies in the country, like Pfizer and CVS Health, weighed in on the proposal during the comment period, arguing for modifications that suit their vision for how di

Insurance 132

Insurance Pharmaceutical Companies Pharmaceutical Companies 132

Fierce Healthcare

SEPTEMBER 17, 2024

Amazon has added virtual behavioral health provider Talkspace to its health conditions program, a service it rolled out in January to help connect customers with virtual care benefits. | Amazon has added virtual behavioral health provider Talkspace to its health conditions program, a service it rolled out in January to help connect customers with virtual care benefits.

129

129

STAT

SEPTEMBER 17, 2024

STAT senior writer Helen Branswell answers the most frequently asked questions about what is happening with mpox now and what can be done to stop this current outbreak.

131

131

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

SEPTEMBER 17, 2024

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. | Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers.

Compounding 128

Compounding Labelling 128

STAT

SEPTEMBER 17, 2024

Reetam Ganguli once pitched his technology, to rescue women from pregnancy complications, in an airplane bathroom. He often works all night, when other recent college graduates are partying. And he sometimes goes weeks without seeing his girlfriend — or any friend at all. But in the midst of his sacrifices, things are looking up.

124

124

Fierce Healthcare

SEPTEMBER 17, 2024

The Biden administration met World Patient Safety Day with a blitz of new programs, panel discussions and commitments from government agencies as well as healthcare industry organizations all focus | A patient safety forum held at the White House came with several agency announcements and discussions with health systems tackling harm reduction and workforce culture.

123

123

STAT

SEPTEMBER 17, 2024

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department. Its agenda illustrates a department excitedly working through how AI fits into its mission — as well as into the United States’ broader health care syste

Medical Schools 124

Medical Schools FDA Hospitals 124

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

SEPTEMBER 17, 2024

Rising costs, technological advancements, the growing complexity of patient needs – these are all factors transforming the specialty pharma landscape at present. | Dive into the future of specialty pharmacy with Tricia Purdy, SVP at Optum Rx. From cross-benefit management to value-based care models, discover how the company is transforming patient care while addressing cost pressures.

Specialty Pharmacies 119

Specialty Pharmacies Patient Care 119

STAT

SEPTEMBER 17, 2024

A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount program. In a letter sent on Tuesday, the U.S. Health Resources and Services Administration maintained that a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices would violate federal law.

Hospitals 122

Hospitals 122

Fierce Healthcare

SEPTEMBER 17, 2024

Employers hold significant power in the healthcare industry. | In this week's episode of "Podnosis," we're diving into the healthcare topics employers are watching most closely.

116

116

STAT

SEPTEMBER 17, 2024

The field of psychedelics, once relegated to the fringes of science and medicine, is in the midst of both transformation and flux. Several key figures stand out in their efforts to push forward the advancement of psychedelic medicine, in the face of ongoing controversy , regulatory hurdles , and stigma. Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and DMT can offer real hope to millions of people who suffer from men

121

121

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

SEPTEMBER 17, 2024

The treatment significantly reduced risk of occurrence by 25% compared with endocrine therapy alone.

FDA 111

FDA 111

STAT

SEPTEMBER 17, 2024

Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers, significantly expanding the number of patients who will have access to this type of drug.

FDA 112

FDA 112

pharmaphorum

SEPTEMBER 17, 2024

Tobacco giant PMI is selling pharma unit Vectura for a fraction of the £1.

111

111

Outsourcing Pharma

SEPTEMBER 17, 2024

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.

FDA 110

FDA 110

pharmaphorum

SEPTEMBER 17, 2024

Boehringer will file its idiopathic pulmonary fibrosis drug nerandolimast next year, a successor to its blockbuster Ofev, after a phase 3 win

110

110

Pharmacy Times

SEPTEMBER 17, 2024

In 2021, cancer diagnosis rates remained low after major disruptions during the first year of the COVID-19 pandemic.

106

106

pharmaphorum

SEPTEMBER 17, 2024

Mitigating diagnostic errors in clinical trial participants: The role of drug safety/pharmacovigilance Mike.

108

108

PioneerRx

SEPTEMBER 17, 2024

As you well know, there are countless ways to make more money for your pharmacy. From leveraging your pharmacy technology to expanding your clinical services.

Labelling 105

Labelling 105

pharmaphorum

SEPTEMBER 17, 2024

Apple has the FDA authorisation it needs to bring its software for detecting sleep apnoea to the Apple Watch, coinciding with the launch of its new operating system for the wearable.The Breathing Disturbances function is part of watchOS 11, which makes its debut today alongside the release of the latest Apple Watch Series 10 which was revealed at the company's new product reveal earlier this month and is due to become available on 20th September.

FDA 105

FDA 105

Pharmacy Times

SEPTEMBER 17, 2024

Eversense 365 (Senseonics) is the first long-lasting continuous glucose monitoring (CGM) system, which includes a 365-day sensor and only 1 insertion on Day 1 of every year.

FDA 101

FDA 101

pharmaphorum

SEPTEMBER 17, 2024

This article discusses the critical importance of payer-provider collaboration in the Medicare system, highlighting its impact beyond prior authorisation processes. Learn more about how collaboration between payers and providers can improve patient outcomes and streamline healthcare delivery.

103

103

Pharmacy Times

SEPTEMBER 17, 2024

The efficacy and safety profiles of CAR T-cell and bispecific antibody therapies have led to their investigation in earlier lines of therapy, with several new treatments in development.

101

101

pharmaphorum

SEPTEMBER 17, 2024

MSD and Daiichi Sankyo's patritumab deruxtecan hit its main objective in a phase 3 lung cancer study that reinforces its potential as a new treatment option for patients after first-line treatment with EGFR inhibitors.The HERTHENA-Lung02 study in EGFR-mutated non-small cell lung cancer (NSCLC), involving patients with locally advanced or metastatic disease previously treated with EGFR drugs, revealed a significant improvement in progression-free survival (PFS) compared to a chemotherapy regimen.

Chemotherapy 103

Chemotherapy FDA 103

STAT

SEPTEMBER 17, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. I’m in New York this week with my colleague Adam Feuerstein for the Cantor Fitzgerald Healthcare Conference. Say hi if you’re there and you see us!

FDA 101

FDA 101

Fierce Pharma

SEPTEMBER 17, 2024

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. | An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis' Kisqali and Eli Lilly's Verzenio in early breast cancer.

FDA 99

FDA 99